7.5 mg tirzepatide to semaglutide vs Dose 3-Tirzepatide 7.5 mg with

Thus, due to the nature of the original diagnostic criteria for GHD, and the reticence to consider aging a disease per se, even though disease risk, incidence and severity can be attributed at least in part to declining activity of the GH neuroendcrine axis, the criteria for determining if secretagogue therapy is indicated as an intervention in aging, are less stringent than those promulgated by Endocrine Society guidelines

Tirzepatide and semaglutide are both weekly GLP-1 receptor agonists used to treat type 2 diabetes and support weight loss

1974, doi: 10.1016/0014-5793(74)81174-9

Controlled data showing benefit from protein-rich foods or delaying fluid intake are not available in the literature